Table 2. Sum of medical expenditures of gynecologic cancer patients by type of service and cancer type, 2007–2014*.
| Costs by type of service | Overall (n=609,787) | Uterine cancer (n=221,848) | Cervical cancer (n=212,101) | Ovarian cancer (n=65,937) | ||||
|---|---|---|---|---|---|---|---|---|
| Hospital inpatient stay | $2,028,247,359 | 53% | $959,270,979 | 63% | $235,549,768 | 48% | $454,728,050 | 51% |
| Office-based medical provider | $559,358,549 | 15% | $183,164,214 | 12% | $98,811,698 | 20% | $100,637,439 | 11% |
| Outpatient department | $487,649,416 | 13% | $201,434,489 | 13% | $88,188,227 | 18% | $98,832,487 | 11% |
| Home health care | $302,984,914 | 8% | $144,385,891 | 9% | $9,132,439 | 2% | $56,619,941 | 6% |
| Emergency room | $36,702,336 | 1% | $5,340,525 | 0% | $612,547 | 0% | $1,907,735 | 0% |
| Prescription medication | $2,107,417 | 0% | $589,257 | 0% | $133,866 | 0% | $1,206,905 | 0% |
| Others† | $420,361,715 | 11% | $25,885,286 | 2% | $57,928,166 | 12% | $180,596,142 | 20% |
| Total | $3,837,411,706 | $1,520,070,641 | $490,356,711 | $894,528,699 | ||||
Number is indicated total number of patients in the US population (calculated by using Medical Expenditure Panel Survey weights) and % is indicated weighted percentage.
*All monetary values were converted to 2014 dollars using the price indices recommended by Agency for Healthcare Research and Quality; †Others medical expenditures include visual aids, medical equipment, supplies, and other medical items.